{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:37:29Z","timestamp":1778816249894,"version":"3.51.4"},"reference-count":58,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.1224","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T05:56:19Z","timestamp":1137477379000},"page":"1224-1231","source":"Crossref","is-referenced-by-count":34,"title":["The Brugada Syndrome-An Update-"],"prefix":"10.2169","volume":"44","author":[{"given":"Wataru","family":"SHIMIZU","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol <b>20<\/b>: 1391-1396, 1992.","DOI":"10.1016\/0735-1097(92)90253-J"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V<SUB>1<\/SUB> through V<SUB>3<\/SUB>. A marker for sudden death in patients without demonstrable structural heart disease. Circulation <b>97<\/b>: 457-460, 1998.","DOI":"10.1161\/01.CIR.97.5.457"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Alings M, Wilde A. &ldquo;Brugada&rdquo; syndrome: Clinical data and suggested pathophysiological mechanism. Circulation <b>99<\/b>: 666-673, 1999.","DOI":"10.1161\/01.CIR.99.5.666"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000046046.53721.90"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1161\/hc1102.105288"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000034169.45752.4A"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/hc0102.101354"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada Syndrome. Report of the Second Consensus Conference. Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation <b>111<\/b>: 659-670, 2005.","DOI":"10.1161\/01.CIR.0000152479.54298.51"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01239-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation <b>95<\/b>: 2277-2285, 1997.","DOI":"10.1161\/01.CIR.95.9.2277"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Matsuo K, Shimizu W, Kurita T, Inagaki M, Aihara N, Kamakura S. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol <b>9<\/b>: 508-512, 1998.","DOI":"10.1111\/j.1540-8167.1998.tb01843.x"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00613-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation <b>96<\/b>: 2595-2600, 1997.","DOI":"10.1161\/01.CIR.96.8.2595"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.3.337"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01867-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Eckardt L, Probst V, Smits JP, et al. Long-term rognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation <b>111<\/b>: 257-263, 2005.","DOI":"10.1161\/01.CIR.0000153267.21278.8D"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Shimizu W. Editorial comment, Gender difference and drug challenge in Brugada syndrome. J Cardiovasc Electrophysiol <b>15<\/b>: 70-71, 2004.","DOI":"10.1046\/j.1540-8167.2004.03557.x"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000032002.22105.7A"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2003.t01-1-00227.x"},{"key":"20","unstructured":"20) Shimizu W, Matsuo K, Satomi K, et al. Role of testosterone on male predominance in Brugada syndrome. Circulation <b>110<\/b>: III-500, 2004."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1332"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2004.03601.x"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02167-8"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2001.01423.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Shimizu W, Matsuo K, Takagi M, et al. Body surface distribution and response to drugs of ST segment elevation in the Brugada syndrome: Clinical implication of 87-leads body surface potential mapping and its application to 12-leads electrocardiograms. J Cardiovasc Electrophysiol <b>11<\/b>: 396-404, 2000.","DOI":"10.1111\/j.1540-8167.2000.tb00334.x"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01962-9"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.07.005"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01197-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation <b>101<\/b>: 510-515, 2000.","DOI":"10.1161\/01.CIR.101.5.510"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2000.01320.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Shimizu W, Aiba T, Kurita T, Kamakura S. Paradoxical abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol <b>12<\/b>: 1418-1421, 2001.","DOI":"10.1046\/j.1540-8167.2001.01418.x"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.06.004"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Wolpert C, Echternach C, Veltmann C, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm <b>2<\/b>: 254-260, 2005.","DOI":"10.1016\/j.hrthm.2004.11.025"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shimizu W. Acquired Forms of Brugada Syndrome (Antzelevitch C review). in: The Brugada Syndrome: From Bench to Bedside, Chapter 14, Blackwell Futura, UK, 2004: 166-177.","DOI":"10.1002\/9780470994900.ch14"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Goldgran-Toledano D, Sideris G, Kevorkian JP. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med <b>346<\/b>: 1591-1592, 2002.","DOI":"10.1056\/NEJM200205163462020"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2002.01537.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Myers GB. Other QRS-T patterns that may be mistaken for myocardial infarction. IV. Alterations in blood potassium; myocardial ischemia; subepicardial myocarditis; distortion associated with arrhythmias. Circulation <b>2<\/b>: 75-93, 1950.","DOI":"10.1161\/01.CIR.2.1.75"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kataoka H. Electrocardiographic patterns of the Brugada syndrome in right ventricular infarction\/ischemia. Am J Cardiol <b>86<\/b>: 1056, 2000.","DOI":"10.1016\/S0002-9149(00)01351-5"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Noda T, Shimizu W, Taguchi A, et al. ST segment elevation and ventricular fibrillation without coronary spasm by intra coronary injection of acetylcholine and\/or ergonovine maleate in patients with Brugada syndrome. J Am Coll Cardiol <b>40<\/b>: 1841-1847, 2002.","DOI":"10.1016\/S0735-1097(02)02494-4"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Morita H, Fukushima-Kusano K, Nagase S, et al. Sinus node function in patients with Brugada-type ECG. Circ J <b>68<\/b>: 473-476, 2004.","DOI":"10.1253\/circj.68.473"},{"key":"41","unstructured":"41) Kamakura S. Clinical profiles and prognosis of patients with Brugada syndrome. &mdash;A multi-center study for risk stratification and management in Japan&mdash;. Circ J <b>69<\/b>: 289 (Suppl I), 2005."},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1038\/32675"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1161\/hc0602.103618"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Shimizu W, Aiba T, Kamakura S. Mechanisms of disease: Current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med <b>2<\/b>: 408-414, 2005.","DOI":"10.1038\/ncpcardio0268"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Bezzina C, Veldkamp MW, van Den Berg MP, et al. A single Na<SUP>+<\/SUP> channel mutation causing both long-QT and Brugada syndromes. Circ Res <b>85<\/b>: 1206-1213, 1999.","DOI":"10.1161\/01.RES.85.12.1206"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Kyndt F, Probst V, Potet F, et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation <b>104<\/b>: 3081-3086, 2001.","DOI":"10.1161\/hc5001.100834"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Viswanathan PC, Bezzina CR, George AL Jr, Roden DM, Wilde AA, Balser JR. Gating-dependent mechanisms for flecainide action in <i>SCN5A<\/i>-linked arrhythmia syndromes. Circulation <b>104<\/b>: 1200-1205, 2001.","DOI":"10.1161\/hc3501.093797"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Baroudi G, Acharfi S, Larouche C, Chahine M. Expression and intracellular localization of an <i>SCN5A<\/i> double mutant R1232W\/T1620M implicated in Brugada syndrome. Circ Res <b>90<\/b>: E11-E16, 2002.","DOI":"10.1161\/hh0102.102977"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Litovsky SH, Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res <b>62<\/b>: 116-126, 1988.","DOI":"10.1161\/01.RES.62.1.116"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Krishnan SC, Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium: Phase 2 Reentry? Circulation <b>87<\/b>: 562-572, 1993.","DOI":"10.1161\/01.CIR.87.2.562"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation <b>93<\/b>: 372-379, 1996.","DOI":"10.1161\/01.CIR.93.2.372"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation <b>100<\/b>: 1660-1666, 1999.","DOI":"10.1161\/01.CIR.100.15.1660"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Aiba T, Shimizu W, Hidaka I, et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: High resolution optical mapping study. J Am Coll Cardiol 2006 (in press).","DOI":"10.1016\/j.jacc.2005.12.064"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Hermida JS, Denjoy I, Clerc J, et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol <b>43<\/b>: 1853-1860, 2004.","DOI":"10.1016\/j.jacc.2003.12.046"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation <b>110<\/b>: 1731-1737, 2004.","DOI":"10.1161\/01.CIR.0000143159.30585.90"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Shimizu W, Kamakura S. Catecholamines in children with congenital long QT syndrome and Brugada syndrome. J Electrocardiol <b>34<\/b>: 173-175, 2001.","DOI":"10.1054\/jelc.2001.28864"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Tsuchiya T, Ashikaga K, Honda T, Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol <b>13<\/b>: 698-701, 2002.","DOI":"10.1046\/j.1540-8167.2002.00698.x"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2000.01277.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/12\/44_12_1224\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:23:15Z","timestamp":1621444995000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/12\/44_12_1224\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.1224","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}